- NLM Digital Collections - Medicare laboratory test expenditures increased in 2018, despite new rate reductionsPublication: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2020... 08 including metabolite(s) if performed (G0481) 17 PSA (prostate specific antigen) measurement (84153) $25.23 $22.71 4.30 $95. ...
- NLM Digital Collections - Antiandrogen therapies for nonmetastatic castration-resistant prostate cancer : effectiveness ...Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, October 4, 2018... resistant prostate cancer PFS Progression-free survival PSA Prostate specific antigen QALY Quality-adjusted life year QLQ-PR25 Quality of Life Questionnaire— ...
- NLM Digital Collections - Proton beam therapy : final evidence reportPublication: [Boston, MA] : Institute for Clinical and Economic Review, [2014]... therapy for prostate cancer: a rise in the prostate-specific antigen (PSA) ... biochemical measurements associated with liver function. For each item, up ...
- ... health status in men with benign prostatic hyperplasia. Measurement Committee of The ... antigen testing for early detection of prostate cancer? Part ...
- ... impact of informed consent on patient interest in prostate-specific antigen screening [see comments] Wolf AM, et al. Arch ... 2):58-64 Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part ...
- ... 1):34—8 What should men know about prostate-specific antigen screening before giving informed consent? Chan EC, et ... Am J Nephrol 1999; 19(3):377-82 Prostate-specific antigen for prostate cancer screening. Do physician characteristics affect ...
- ... 103(5):410—8 Predictors of interest in prostate-specific antigen screening and the impact of informed consent: what ... 7):2305-12 Preferences of elderly men for prostate-specific antigen screening and the impact of informed consent. Wolf ...
- ... 4):32-8 Clinical practice and new technology: prostate-specific antigen (PSA). Stuart ME, et al. HMO Pract 1992 ... 4):32-8 Clinical practice and new technology: prostate-specific antigen (PSA). Stuart ME, et al. HMO Pract 1992 ...
- ... Apr-May;4(3):259-63 Determinants of prostate-specific antigen test use in prostate cancer screening by primary ... Jul-Aug;12(4):277-81 Determinants of prostate-specific antigen test use in prostate cancer screening by primary ...
- NLM Digital Collections - Racial and ethnic disparities in U.S. health care : a chartbookPublication: [New York, N.Y.] : Commonwealth Fund, March 2008... K. J. Han et al., “Decision Making in Prostate-Specific Antigen 43 percent of blacks and 41 percent of ...
104 results